Second Half Financial Partners LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 36.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,570 shares of the healthcare conglomerate's stock after selling 4,260 shares during the quarter. UnitedHealth Group accounts for about 2.3% of Second Half Financial Partners LLC's investment portfolio, making the stock its 10th largest holding. Second Half Financial Partners LLC's holdings in UnitedHealth Group were worth $4,426,000 as of its most recent SEC filing.
A number of other large investors also recently made changes to their positions in the business. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group during the 3rd quarter worth about $27,000. Global Wealth Strategies & Associates lifted its stake in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock valued at $31,000 after acquiring an additional 32 shares during the last quarter. Macroview Investment Management LLC raised its holdings in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate's stock valued at $28,000 after purchasing an additional 47 shares in the last quarter. West Financial Advisors LLC bought a new stake in UnitedHealth Group in the third quarter worth $32,000. Finally, Bbjs Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the second quarter worth about $31,000. Institutional investors and hedge funds own 87.86% of the company's stock.
Analyst Ratings Changes
UNH has been the subject of several analyst reports. TD Cowen boosted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a "buy" rating in a report on Friday, October 18th. UBS Group decreased their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating for the company in a report on Wednesday, October 16th. Truist Financial restated a "buy" rating and set a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Tuesday, November 12th. Finally, Hsbc Global Res downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Thursday, October 17th. Three research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $615.53.
Read Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Price Performance
NYSE:UNH traded down $12.72 during trading hours on Tuesday, reaching $576.93. The company had a trading volume of 3,142,427 shares, compared to its average volume of 3,879,812. The stock has a 50-day moving average of $582.75 and a two-hundred day moving average of $550.66. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The firm has a market capitalization of $530.94 billion, a PE ratio of 37.84, a PEG ratio of 1.74 and a beta of 0.58.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same quarter last year, the business posted $6.56 earnings per share. The company's revenue was up 9.2% on a year-over-year basis. Analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.46%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group's dividend payout ratio is currently 54.72%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.